Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 110251-110300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04376177
Clinical Routine in Thoracic Outlet Syndrome
N/ARecruiting
1,000 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03885648
Breast Cancer and Its Relationship With the Microbiota
N/AActive, not recruiting
150 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05422664
Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy
N/AEnrolling by invitation
500 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2025
3 conditions8 sponsors1 location
NCT04745143
Monotherapy of an NMDA Enhancer for Schizophrenia
PHASE2Recruiting
80 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03380468
Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma
PHASE2/PHASE3Recruiting
300 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04623580
Flemish Inguinal and Femoral Hernia Prospective Registry
N/ARecruiting
560 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT03446326
Assessment of Stroke Volume and Cardiac Output in Response to Varying Heart Rates
NARecruiting
25 participants
Started: Jan 1, 2018 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT04289389
Prevalence and Level of Diagnosis of Dementia in a Population-based Sample in the County of Trøndelag
N/AActive, not recruiting
11,675 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT06458361
Identification of Risk Factors and Construction of Prediction Model for Postoperative Intestinal Anastomotic Leakage in Ovarian Cancer
N/ARecruiting
300 participants
Started: Jan 1, 2018 · Completed: Nov 1, 2024
1 condition1 sponsor1 location
NCT04483804
Application of Radiomics in Breast Cancer
N/ARecruiting
2,000 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2028
5 conditions1 sponsor1 location
NCT03567538
National Register Studies in Thoracic Surgery
N/AActive, not recruiting
20,000 participants
Started: Jan 1, 2018 · Completed: Jan 1, 2026
3 conditions2 sponsors1 location
NCT04160325
Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery
NARecruiting
54 participants
Started: Jan 1, 2018 · Completed: Oct 31, 2023
1 condition1 sponsor1 location
NCT03584204
Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome
N/ARecruiting
400 participants
Started: Jan 1, 2018 · Completed: Aug 31, 2026
1 condition2 sponsors3 locations
NCT03549416
BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
N/ARecruiting
1,200 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2028
1 condition6 sponsors14 locations
NCT05636605
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
N/ARecruiting
200 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT03326947
Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC
PHASE2Recruiting
60 participants
Started: Jan 1, 2018 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT03720860
Inflammatory Mediators of Acute Kidney Injury in Intensive Care
N/ARecruiting
100 participants
Started: Jan 1, 2018 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT04598672
Cognitive Behavioral Therapy for Insomnia (CBTi) in Patients With Somatic Disease
NAActive, not recruiting
40 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2025
8 conditions1 sponsor1 location
NCT06524713
A 5-Year Anesthetic Evaluation of Cases Undergoing Cesarean Section Delivery ın Our Clinic
N/AActive, not recruiting
2,500 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT03820375
Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke
N/ARecruiting
750 participants
Started: Jan 1, 2018 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT03102554
Genetics of Differences of Sex Development and Hypospadias
NAEnrolling by invitation
300 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04423731
Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)
N/AActive, not recruiting
251 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT04390529
Immediate Breast Reconstruction Following Mastectomy (IRMA)
N/AActive, not recruiting
515 participants
Started: Jan 1, 2018 · Completed: Apr 30, 2030
1 condition1 sponsor15 locations
NCT04567121
Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases(NCD)
NARecruiting
60,000 participants
Started: Jan 1, 2018 · Completed: Dec 1, 2070
2 conditions1 sponsor1 location
NCT03319498
Postpartum Urinary Retention With Essential Oils (PURE)
NAEnrolling by invitation
390 participants
Started: Jan 1, 2018 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT03150914
Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
PHASE3Active, not recruiting
60 participants
Started: Jan 1, 2018 · Completed: Jun 30, 2025
2 conditions4 sponsors8 locations
NCT04467944
Effect of Pre-existing Adjacent Segment Degeneration on Long-term Effectiveness After Lumbar Fusion Surgery
N/ARecruiting
210 participants
Started: Jan 1, 2018 · Completed: Dec 31, 2032
3 conditions1 sponsor1 location
NCT06778226
ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion
N/AActive, not recruiting
5,000 participants
Started: Jan 1, 2018 · Completed: May 1, 2026
1 condition3 sponsors3 locations
NCT05033457
Comparative Study Between UBE and PETD for the Treatment of Lumbar Spinal Canal Stenosis
N/AEnrolling by invitation
100 participants
Started: Jan 1, 2018 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT05728580
PCI in Beijing Friendship Hospital
N/ARecruiting
10,000 participants
Started: Dec 31, 2017 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT03064087
Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples
N/AActive, not recruiting
500 participants
Started: Dec 29, 2017 · Completed: Nov 17, 2027
1 condition7 sponsors5 locations
NCT03272334
Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
PHASE1/PHASE2Active, not recruiting
33 participants
Started: Dec 29, 2017 · Completed: Jan 31, 2031
1 condition2 sponsors1 location
NCT03269630
New Orleans Pulmonary Hypertension Biobank
N/ARecruiting
450 participants
Started: Dec 29, 2017 · Completed: Oct 31, 2027
5 conditions1 sponsor1 location
NCT03391869
Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
PHASE3Recruiting
400 participants
Started: Dec 29, 2017 · Completed: Dec 31, 2025
3 conditions1 sponsor5 locations
NCT03394365
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy
PHASE3Recruiting
66 participants
Started: Dec 29, 2017 · Completed: Aug 31, 2030
5 conditions1 sponsor71 locations
NCT03087071
Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer
PHASE2Active, not recruiting
59 participants
Started: Dec 29, 2017 · Completed: Jan 31, 2026
8 conditions2 sponsors1 location
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
PHASE4Recruiting
100 participants
Started: Dec 28, 2017 · Completed: Dec 21, 2027
5 conditions1 sponsor27 locations
NCT03333616
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
PHASE2Active, not recruiting
100 participants
Started: Dec 28, 2017 · Completed: May 31, 2026
8 conditions2 sponsors6 locations
NCT03388606
Characterization and Treatment of Adolescent Depression
N/ARecruiting
4,100 participants
Started: Dec 28, 2017 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT03328078
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
PHASE1/PHASE2Recruiting
152 participants
Started: Dec 28, 2017 · Completed: Oct 31, 2026
4 conditions1 sponsor43 locations
NCT02802553
Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions
NAActive, not recruiting
2 participants
Started: Dec 28, 2017 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03300817
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer
PHASE1Active, not recruiting
50 participants
Started: Dec 27, 2017 · Completed: Dec 1, 2025
1 condition1 sponsor2 locations
NCT04225572
Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)
NAActive, not recruiting
135 participants
Started: Dec 27, 2017 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03290937
Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer
PHASE1Active, not recruiting
42 participants
Started: Dec 27, 2017 · Completed: Dec 31, 2026
5 conditions2 sponsors1 location
NCT03337698
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)
PHASE1/PHASE2Active, not recruiting
314 participants
Started: Dec 27, 2017 · Completed: Nov 30, 2026
1 condition1 sponsor32 locations
NCT03810651
Pencil Beam Scanning in Patients With Renal Tumors
EARLY_PHASE1Recruiting
28 participants
Started: Dec 26, 2017 · Completed: Oct 30, 2027
2 conditions1 sponsor1 location
NCT03319940
Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)
PHASE1Active, not recruiting
269 participants
Started: Dec 26, 2017 · Completed: Oct 18, 2026
1 condition1 sponsor39 locations
NCT03726359
Phase I Study of Fractionated Stereotactic Radiation Therapy
PHASE1Recruiting
43 participants
Started: Dec 25, 2017 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT02838602
Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
NARecruiting
250 participants
Started: Dec 23, 2017 · Completed: Dec 23, 2026
1 condition1 sponsor21 locations
NCT03366844
Breast Cancer Study of Preoperative Pembrolizumab + Radiation
PHASE1/PHASE2Active, not recruiting
66 participants
Started: Dec 22, 2017 · Completed: Dec 7, 2030
1 condition2 sponsors1 location